About Daniel Crowley

Dan Crowley is co-founder and CEO of RemedyBio, and is focused on strategic leadership of the company, supporting our great team, and building transformational partnerships with industry leaders. Prior to RemedyBio, Dan co-founded and led Genomics Medicine Ireland (acquired in 2018) and was a Venture Partner with ARCH Venture Partners.

He serves on the board of the AMBER Centre for Advanced Materials and Bioengineering Research headquartered at Trinity College Dublin. Dan holds a BA and MSc from Trinity College Dublin, a PDip from Oxford University, received his MBA from Cornell where he was an Angear Merit Scholar, and is a Kauffman Fellow.